Choi Wan Chan

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy

Alex Molassiotis, Huilin Cheng, Violeta López et al. · BMC Cancer · 2019 · 202 citations · Full text

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy

Alex Molassiotis, Huilin Cheng, Kwun To Leung et al. · Brain and Behavior · 2019 · 113 citations · Full text

Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy

Huilin Cheng, Violeta López, Simon Ching Lam et al. · Health and Quality of Life Outcomes · 2020 · 58 citations · Full text

New-onset insomnia among cancer patients undergoing chemotherapy: prevalence, risk factors, and its correlation with other symptoms

Huong Thi Xuan Hoang, Alex Molassiotis, Choi Wan Chan et al. · Sleep And Breathing · 2019 · 53 citations

Sleep, Medicine, Cancer Management +6

Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy

Fiona Yeo, Chiu Chin Ng, Kiley Wei-Jen Loh et al. · Supportive Care in Cancer · 2019 · 50 citations

Neuro-oncology, Peripheral Neuropathy, Medicine +8